Biomarker Validation for Aging: Lessons from mtDNA Heteroplasmy Analyses in Early Cancer Detection
The anticipated biological and clinical utility of biomarkers has attracted significant interest recently. Aging and early cancer detection represent areas active in the search for predictive and prognostic biomarkers. While applications differ, overlapping biological features, analytical technologi...
Main Authors: | Peter E. Barker, Mahadev Murthy |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2009-11-01
|
Series: | Biomarker Insights |
Online Access: | http://la-press.com/biomarker-validation-for-aging-lessons-from-mtdna-heteroplasmy-analyse-a1755 |
Similar Items
-
Biomarker Validation for Aging: Lessons from mtDNA Heteroplasmy Analyses in Early Cancer Detection
by: Peter E. Barker, et al.
Published: (2009-01-01) -
Age-Related and Heteroplasmy-Related Variation in Human mtDNA Copy Number.
by: Manja Wachsmuth, et al.
Published: (2016-03-01) -
mtDNA Heteroplasmy: Origin, Detection, Significance, and Evolutionary Consequences
by: Maria-Eleni Parakatselaki, et al.
Published: (2021-06-01) -
Cellular Heterogeneity in the Level of mtDNA Heteroplasmy in Mouse Embryonic Stem Cells
by: Jitesh Neupane, et al.
Published: (2015-11-01) -
Analyzing Low-Level mtDNA Heteroplasmy—Pitfalls and Challenges from Bench to Benchmarking
by: Federica Fazzini, et al.
Published: (2021-01-01)